INS and metabolic dysfunction-associated steatotic liver disease: In summary, hepatic lipid accumulation and MASLD development are influenced by multiple factors, including DNL activity, oxidative stress, hepatic insulin clearance, fructose consumption, the activity of PPARs, and lipoprotein profile.